UCL DEPARTMENT OF BIOCHEMICAL ENGINEERING

(24-26 June 2013) £1,300

This unique module will introduce options for integrating biocatalysis into chemical manufacturing processes, and also explore successful examples of biocatalyst design, process operation and biorefining for sustainable manufacturing.

In this module a series of lectures, problem solving case studies, and a discussion workshop will provide close interaction with key academic and industrial speakers, enabling you to:
• Strengthen your knowledge in biocatalysis, and whole biotransformation processes, from fermentation to product.
• Understand the available chemistries in biocatalysis, and their use in industrial applications.
• Evaluate biological engineering and reaction engineering options.
• Explore the challenges and options for large scale biocatalysis/ biorefining process development.

Teaching Staff:
Dr. Paul Dalby (Module Leader) UCL;  Dr. Frank Baganz UCL;  Prof. Gary Lye UCL;  Harvey Branton (CPI), Dr Christopher Reeve (CPI), Steve Pearson (CPI) Jonathan Robinson (CPI)

Module delivered at CPI, Wilton.

Suitable for:
•    
•    Process engineers
•    Biocatalyst developers & biologists
•    Chemists
•    Molecular Biologists
•    Microbiologists
•    Research managers
•    Consultants

More details > www./ucl.ac.uk/biochemeng/mbi

16 May 2013

UCL has been awarded a share of a government investment of £50m into UK’s leading universities to drive growth, the Minister for Universities and Science has announced.

University College London (UCL) has joined forces with The Centre for Process Innovation (CPI) to form a new training collaboration in the area of Industrial Biotechnology and Biorefining. We have jointly developed a new module in this area as part of the UCL Biochemical Engineering Modular Training for the Bioprocess Industries (MBI®) Programme.

19th July 2012 

From 16th to 19th July, 25 budding engineers attended a four-day Biochemical Engineering course at University College London (UCL).  The course provided 15 and 16 year old students with the opportunity to learn about novel biological therapeutics theories and the importance of biochemical engineering in transforming these life-saving medicines into drugs that are commercially available.

A team made up of 4 UCL Biochemical Engineering students (Freedanz Ferdinandz, Ali Versi, Udit Varma, Si U Sou) and 2 UCL Biotechnology students (Kheng Ng, Khai Kong) won 1st prize in the 2012 Abbott Innovation University Challenge worth $10,000. The team put forward a concept paper to address the Abbott Challenge on: ‘Identification and support of patients with pancreatic exocrine insufficiency’.

UCL Biochemical Engineering and GE Healthcare have been working closely together in a number of ways thanks to the drive and enthusiasm of UCL EngD alumnus,  Dr Naveraj Gill, who is now a ReadyToProcess Product Specialist within GE Healthcare.

The Department of Biochemical Engineering has won one of only four pilot EPSRC Manufacturing Fellowships awarded to Dr Ajoy Velayudhan to work with Prof Nigel Titchener-Hooker. Over the five year appointment it is hoped to establish, in the UK, a new area of interdisciplinary research in the rational design of processes for the cost-effective manufacture of therapeutic proteins. Dr Velayudhan has an established academic as well as industrial track record in the USA and will be joining UCL in the Autumn. The success is particularly important to the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies as it increases the breadth of the studies that can be explored and the range of industry partners who will join the consortium.